| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income (loss) | 46,984 | 50,582 |
| Depreciation and amortization | 170,757 | 113,438 |
| Non-cash operating lease costs | 5,603 | 4,325 |
| Share-based compensation | 33,676 | 21,479 |
| Provision for credit losses on accounts receivable | 2,493 | 1,012 |
| Provision for credit losses | 17,566 | - |
| Deferred income taxes, net | 1,167 | -7,320 |
| Loss on sale of businesses | 0 | 0 |
| Goodwill impairment | 17,579 | - |
| Changes in fair value of contingent consideration | -2,834 | -2,318 |
| Income from equity method investments, net | -11,783 | -11,745 |
| Gain (loss) on investments, net | 5,018 | 4,340 |
| Other | 2,403 | 1,701 |
| Accounts receivable | -187,760 | -147,417 |
| Prepaid expenses and other current assets | 10,325 | 523 |
| Other assets | -14,658 | -1,900 |
| Accounts payable | -240,398 | -231,065 |
| Deferred revenue | -4,708 | 464 |
| Accrued liabilities and other current liabilities | -9,594 | -7,320 |
| Net cash provided by operating activities | 215,986 | 77,687 |
| Purchases of property and equipment | 85,888 | 55,752 |
| Acquisitions, net of cash received | 67,086 | 50,345 |
| Distribution from equity method investment | 10,756 | 9,196 |
| Proceeds from sale of equity method investment | 860 | - |
| Proceeds from sale of equity investments | 25,250 | 25,250 |
| Proceeds from sale of businesses, net of cash divested | 0 | 0 |
| Other | 263 | -51 |
| Net cash used in investing activities | -116,371 | -71,600 |
| Payment of debt | 0 | - |
| Repurchase of common stock | 113,221 | 68,834 |
| Issuance of common stock under employee stock purchase plan | 3,751 | 3,751 |
| Deferred payments for acquisitions | 213 | 213 |
| Other | -1,783 | -1,592 |
| Net cash used in financing activities | -111,466 | -66,888 |
| Effect of exchange rate changes on cash and cash equivalents | 9,339 | 12,180 |
| Net change in cash and cash equivalents | -2,512 | -48,621 |
| Cash and cash equivalents at beginning of period | 505,880 | - |
| Cash and cash equivalents at end of period | 503,368 | - |
ZIFF DAVIS, INC. (ZD)
ZIFF DAVIS, INC. (ZD)